Company Filing History:
Years Active: 2015
Title: Young Sun Oh - Innovator in Cancer Treatment
Introduction
Young Sun Oh is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for cancer treatment. His innovative approach has the potential to impact the lives of many patients battling this disease.
Latest Patents
Young Sun Oh holds a patent for the use of a novel aminopyridine derivative to prevent or treat cancer. This patent describes an aminopyridine derivative of Formula 1, which includes specific structural components that enhance its efficacy. The formula outlines that X1 and X2 can be either carbon or nitrogen, while R1 to R5 can be hydrogen, various alkyl groups, halogens, or hydroxyl groups. Additionally, R6 can be hydrogen or an alkyl group of C1-C6. This innovative compound represents a promising avenue for cancer therapy.
Career Highlights
Young Sun Oh is affiliated with the Medicinal Bioconvergence Research Center, where he conducts research aimed at developing effective treatments for cancer. His work is characterized by a strong focus on the synthesis and application of new chemical entities that can provide therapeutic benefits.
Collaborations
He collaborates with notable colleagues, including Sunghoon Kim and Hee S Lee, who contribute to his research efforts. Their combined expertise enhances the potential for groundbreaking discoveries in the field of medicinal bioconvergence.
Conclusion
Young Sun Oh's innovative work in cancer treatment exemplifies the critical role of inventors in advancing medical science. His patent for a novel aminopyridine derivative showcases his commitment to finding effective solutions for complex health challenges.